Mydriatics, cycloplegics and miotics
The pupil and the focusing muscle are controlled by the autonomic nervous system, so drugs that mimic or block autonomic transmitters are the everyday tools of the eye clinic. This lesson covers the drops that dilate the pupil, the drops that paralyse focusing and the drops that constrict the pupil, with their durations, uses and dangers. It ends with the drops used to test an abnormal pupil, where the result only makes sense if the pharmacology is understood.
Three muscles and two transmitters
Three smooth muscles inside the eye matter here. The iris sphincter is a ring of muscle at the pupil margin. It is driven by parasympathetic fibres that travel with the third cranial nerve, synapse in the ciliary ganglion and release acetylcholine onto muscarinic receptors. When it contracts the pupil gets smaller, which is miosis. The iris dilator runs radially like the spokes of a wheel. It is driven by sympathetic fibres that release noradrenaline onto alpha-1 receptors. When it contracts the pupil enlarges, which is mydriasis. The ciliary muscle has the same parasympathetic, muscarinic supply as the sphincter. When it contracts the zonules slacken, the lens becomes rounder and the eye focuses for near, which is accommodation. Paralysis of accommodation is cycloplegia.
3D atlasThe iris holds the sphincter and dilator; the ciliary body holds the ciliary muscle that controls the lens through the zonules.From this, every drug in the lesson can be predicted. Blocking muscarinic receptors paralyses the sphincter and the ciliary muscle together, giving a large pupil that cannot focus. Stimulating alpha-1 receptors contracts the dilator, giving a large pupil with focusing intact. Stimulating muscarinic receptors contracts the sphincter and the ciliary muscle, giving a small pupil and an eye pulled into near focus.
| Group | Receptor action | Pupil | Accommodation | Examples |
|---|---|---|---|---|
| Antimuscarinic | Blocks muscarinic receptors | Dilates | Paralysed | Tropicamide, cyclopentolate, atropine |
| Sympathomimetic | Stimulates alpha-1 receptors | Dilates | Unaffected | Phenylephrine |
| Miotic (parasympathomimetic) | Stimulates muscarinic receptors | Constricts | Spasm, with induced short sight | Pilocarpine |
Antimuscarinics: tropicamide, cyclopentolate and atropine
The three antimuscarinics do the same thing and differ in strength and duration. The BNF describes them as varying in potency and duration of action, and gives the figures in the table.
| Drug | Duration (BNF) | Cycloplegia | Main use |
|---|---|---|---|
| Tropicamide | Up to 6 hours | Weak | Dilating the pupil to examine the fundus |
| Cyclopentolate | Recovery can take up to 24 hours | Strong | Cycloplegic refraction in children; uveitis |
| Atropine | Up to 7 days | Strongest | Severe or persistent uveitis; specialist uses in children |
Tropicamide is the routine clinic dilating drop because it works quickly and wears off the same day. Its effect on focusing is weak, so it is not reliable for refraction in a child.
Cyclopentolate is the standard drop for cycloplegic refraction. A child can accommodate powerfully, and that effort hides long sight (hypermetropia) during a sight test. Paralysing the ciliary muscle reveals the full refractive error, which is essential in any child with a squint or suspected amblyopia. The BNF dose is one drop 30 to 60 minutes before the examination, using 1% from 3 months to 11 years and 0.5% from 12 to 17 years.
Atropine is the most potent and by far the longest acting. It is used when prolonged cycloplegia is wanted. Paediatric ophthalmologists also use it to blur the better eye in the treatment of amblyopia, and a low-dose atropine drop is now licensed to slow the progression of short sight in children aged 3 to 14 years, started by a specialist.
In anterior uveitis an antimuscarinic is given alongside the steroid for two reasons stated in the BNF. Holding the pupil wide and moving stops the inflamed iris sticking to the lens, which prevents posterior synechiae. Paralysing the ciliary muscle relieves the spasm that causes much of the pain.
Risks of dilating a pupil
Dilating drops are very safe, but three risks are examinable.
- Acute angle closure. In an eye with a shallow anterior chamber, a mid-dilated pupil can crowd the iris into the drainage angle. The BNF describes the typical patient as over 60 and long-sighted. The risk is small, and it is not a reason to avoid dilating a patient who needs a fundus examination, but anyone who develops a painful red eye with haloes afterwards needs urgent review.
- Systemic antimuscarinic effects. The BNF lists flushing, dry mouth, dry skin, tachycardia, constipation, urinary problems, and in children abnormal behaviour and psychosis. Children and older people are the most susceptible. Cyclopentolate and atropine cause this far more than tropicamide.
- Blurred vision and glare. Patients should not drive or do other skilled tasks until vision has cleared.
Two further BNF cautions apply to all antimuscarinic eye drops. They are used with caution under 3 months of age because of a possible link between cycloplegia and amblyopia. A darkly pigmented iris binds the drug and dilates more slowly, and the response should be waited for instead of adding repeated drops.
Phenylephrine
Phenylephrine is a sympathomimetic that stimulates alpha-1 receptors on the iris dilator. It dilates the pupil without touching accommodation. According to the BNF, mydriasis occurs within 60 to 90 minutes and lasts up to 5 to 7 hours. It is commonly added to tropicamide when a very wide pupil is needed, for example before cataract or retinal surgery, because the two drugs act on different muscles and their effects add.
Alpha-1 stimulation also constricts blood vessels. On the eye this blanches the superficial conjunctival and episcleral vessels. In the body it can raise blood pressure. The BNF contraindicates the 10% strength in children and in older people, and lists hypertension, cardiovascular disease, aneurysms and thyrotoxicosis as contraindications to phenylephrine eye drops. Myocardial infarction has been reported, usually after the 10% strength in patients with existing cardiovascular disease. The 2.5% strength is therefore preferred.
Pilocarpine and miosis
Pilocarpine is a muscarinic agonist: it acts like acetylcholine on the sphincter and the ciliary muscle. Its two actions explain both its uses and its side effects. Contraction of the sphincter makes the pupil small, which pulls the peripheral iris away from the drainage angle. Contraction of the ciliary muscle pulls on the scleral spur and opens up the trabecular meshwork, so aqueous drains more easily and pressure falls. The BNF describes this as opening the inefficient drainage channels in the trabecular meshwork.
Its main role today is in angle closure, covered in the glaucoma chapter. The side effects are the price of a contracted ciliary muscle and a small pupil:
- A brow ache from ciliary spasm.
- Induced short sight, because the lens is held in its near-focus shape. This troubles young patients most.
- Dim vision, especially at night, because the small pupil lets in less light. The BNF warns about driving in reduced lighting.
- Retinal detachment, which has occurred in susceptible people. The BNF advises a fundus examination before starting a miotic.
- Systemic cholinergic effects such as sweating, salivation, bradycardia and bronchospasm.
Drops used to test an abnormal pupil
When the two pupils are unequal, drops can show which nerve supply has failed. The clinical approach is in the neuro-ophthalmology chapter. The pharmacology rests on one idea: denervation supersensitivity. A muscle that has lost its nerve supply makes more receptors, so it over-responds to a weak dose of agonist that would do nothing to a normal muscle.
In Horner syndrome the sympathetic supply to the dilator is interrupted and the affected pupil is the smaller one. Three drops are described:
- Cocaine (4 to 10%) blocks the reuptake of noradrenaline at the nerve ending. A normal pupil dilates because noradrenaline that is being released builds up. A Horner pupil does not, because no noradrenaline is being released. The difference between the pupils increases.
- Apraclonidine (0.5 to 1%) is mainly an alpha-2 agonist with weak alpha-1 activity. The weak alpha-1 effect is too little to move a normal pupil, but the supersensitive Horner pupil dilates, so the anisocoria reverses. Supersensitivity takes about 5 to 8 days to develop, so the test can be falsely negative in a very recent Horner. It is avoided in infants because of central nervous system depression.
- Hydroxyamphetamine (1%) releases stored noradrenaline from the final (third-order) neurone. If that neurone is intact the pupil dilates, so the lesion is central or preganglionic. If it fails to dilate the lesion is postganglionic. This drop is now hard to obtain.
When the larger pupil is the abnormal one, pilocarpine is the test drug. In an Adie tonic pupil the lesion is in the ciliary ganglion, the sphincter is denervated and supersensitive, and it constricts to dilute pilocarpine (0.1 to 0.125%), which is too weak to affect a normal pupil. If a fixed dilated pupil does not respond to the dilute drop, full-strength pilocarpine 1% is tried. A pupil paralysed by a third nerve palsy constricts, because its muscle and receptors are healthy. A pupil dilated by an antimuscarinic drug does not, because its receptors are blocked.
| Drop | Suspected problem | Positive result | Why |
|---|---|---|---|
| Cocaine 4 to 10% | Horner syndrome | Affected pupil fails to dilate | No noradrenaline is being released to accumulate |
| Apraclonidine 0.5 to 1% | Horner syndrome | Affected pupil dilates; anisocoria reverses | Supersensitive alpha-1 receptors |
| Hydroxyamphetamine 1% | Localising a Horner | No dilation means postganglionic lesion | Needs an intact third-order neurone |
| Pilocarpine 0.1 to 0.125% | Adie tonic pupil | Affected pupil constricts | Supersensitive muscarinic receptors |
| Pilocarpine 1% | Fixed dilated pupil | No constriction means drug-induced mydriasis | Receptors are blocked by an antimuscarinic |
Summary
- The sphincter and ciliary muscle are muscarinic; the dilator is alpha-1 adrenergic.
- Antimuscarinics dilate the pupil and paralyse accommodation; phenylephrine dilates without cycloplegia.
- Tropicamide lasts up to 6 hours, cyclopentolate up to 24 hours and atropine up to 7 days.
- Cyclopentolate is the standard drop for cycloplegic refraction in children.
- In anterior uveitis a cycloplegic prevents posterior synechiae and relieves ciliary spasm.
- Mydriasis can precipitate angle closure in a long-sighted older patient with a shallow anterior chamber.
- Phenylephrine 10% is contraindicated in children and older people because of its cardiovascular effects.
- Pilocarpine opens the trabecular meshwork by contracting the ciliary muscle, and causes brow ache, induced myopia and rarely retinal detachment.
- Apraclonidine reverses the anisocoria of Horner syndrome; dilute pilocarpine constricts an Adie pupil.
- A pharmacologically dilated pupil fails to constrict to pilocarpine 1%, whereas a third nerve pupil constricts.
Check yourself
Quick recall on this lesson. These are easier than the question bank.
Written for revision. It is not a source of clinical advice, and guidance changes.